Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Gilead bags Genmab tech to develop bispecific antibody against HIV

Editor's pick
FierceBiotech
12 August 2016
HIV prevention policy

As EU Approval Moves Closer Are Governments Prepared For PrEP?

Editor's pick
Seeking Alpha
27 July 2016
Access to healthcare

South Africa: Produce HIV Drugs Locally, Says Science Minister

Editor's pick
AllAfrica
22 July 2016
PrEP

HIV Drug Pricing Protest Interrupts PrEP Session at AIDS 2016

Editor's pick
BETA blog
21 July 2016
Testing & health monitoring

Challenges Loom for Point-of-Care Diagnostics

Editor's pick
Genetic Engineering & Biotechnology News
13 July 2016
Pharmaceutical industry

Gilead defeats AIDS activists who claimed the company manipulated patents

Editor's pick
STAT
13 July 2016
Access to healthcare

The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments

Editor's pick
Medicines Patent Pool
11 July 2016
Pharmaceutical industry

Gilead’s new price hikes on HIV drugs anger AIDS activists

Editor's pick
STAT
6 July 2016
Pharmaceutical industry

How To Avoid Black Market HIV Drugs

Editor's pick
HIV Plus
4 July 2016
Pharmaceutical industry

Brexit spells upheaval for EU and UK drug regulation

Editor's pick
Reuters
30 June 2016
New & experimental HIV treatments

Gilead’s single tablet regimen Odefsey receives European marketing approval for HIV treatment

Editor's pick
PharmaBiz
27 June 2016
Pharmaceutical industry

What Do Gilead And Martin Shkreli Have In Common?

Editor's pick
Seeking Alpha
22 June 2016
Pharmaceutical industry

Cipla in pact with Russian firm for HIV, Hepatitis C drugs

Editor's pick
Moneycontrol
20 June 2016
Pharmaceutical industry

HLM 2016 AIDS: Universal treatment access panel looks at issues in generic antiretroviral medicines

Editor's pick
Science Speaks
12 June 2016
Pharmaceutical industry

Gilead escapes liability in hepatitis C patent fight with Merck

Editor's pick
Reuters
7 June 2016
Hepatitis C treatment

Patients who pay £1,000 for life-saving drugs online that would cost NHS £35,000: More and more are doing it - but doctors warn it's a big risk

Editor's pick
Daily Mail
1 June 2016
Pharmaceutical industry

A question of timing: A lawsuit claims Gilead Sciences could have developed a less-harmful version of its HIV treatment sooner

Editor's pick
Los Angeles Times
30 May 2016
New & experimental hepatitis C treatment

European CHMP Adopts Positive Opinion for Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C

Editor's pick
Gilled press relase
27 May 2016
Access to healthcare

Gilead's $1000 hepatitis C pill gets patent in India

Editor's pick
Times of India
10 May 2016
Pharmaceutical industry

Sky-high price of hepatitis C drug produces profits for lawmakers

Editor's pick
Center for Responsive Politics
5 May 2016
Pharmaceutical industry

'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier

Editor's pick
Fierce Pharma
3 May 2016
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV

Editor's pick
Gilead press release
25 April 2016
PrEP

Gilead Statement on the Approval of PrEP in Peru

Editor's pick
Gilead Sciences
14 April 2016
Access to healthcare

Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

Editor's pick
World Hepatitis Alliance
14 April 2016